The merger of Ciba-Geigy and Sandoz is based on genomic interaction in the field of health, agriculture and food additives. How to build on the strength of individual units and to create synergy that will continue to lead Novartis "is the issue facing the company." Hide
by Ray A. Goldberg, Carin-Isabel Knoop, Srinivas Ramdas Sunder Source: Harvard Business School 22 pages. Publication Date: December 10, 1998. Prod. #: 599076-PDF-ENG
Related Case Solutions & Analyses:
Housing Investment
Curt Schillings Next Pitch
How to Convince Skeptical Investors
Hydrofruit Inc.: Ripe for Harvest or Rotten Tomato
Minova (D)
Tad Piper and Piper Jaffray
Negotiating Your Entry into Your Family Business
Time Distribution and Interaction Patterns for PEARL Project Team: Work Patterns at Ditto (D)
Donna Dubinsky and Apple Computer Inc. (B)
Sustainable Tourism: Heritance Kandalama Resort of Sri Lanka
